Biosurgery Market
Biosurgery Market Size, Share & Trends Analysis By Product Type (Bone-Graft Substitutes, Hemostatic Agents, Surgical Sealants & Adhesives, Adhesion Barriers, Soft-Tissue Attachments, Staple-Line Reinforcement, and Others), By Application (Orthopedic Surgery, General Surgery, Neurological Surgery, Cardiovascular Surgery, Gynecological Surgery, and Thoracic & Reconstructive Surgery), and by End-User (Hospitals & clinics, Ambulatory Surgical Centers (ASCs), and Others) Forecast Period (2026-2035)
Industry Overview
Biosurgery market was valued at $16.9 billion in 2025 and is projected to reach $35.5 billion by 2035, growing at a CAGR of 7.7% during the forecast Period (2026-2035). The market is driven by factors like the increasing prevalence of chronic diseases, a growing elderly population, and a rise in surgical procedures. Key drivers also include technological advancements in medical devices and biosurgical products, increased demand for effective blood loss management, and a greater incidence of accidents and sports-related injuries.
Market Dynamics
Increasing Surgical Volumes and Trauma Incidents
A primary driver for the global biosurgery market is the rising number of surgical procedures worldwide, including those prompted by trauma and chronic?disease complications. According to one forecast, the need for effective blood?loss management in surgical and trauma settings is accelerating the uptake of biosurgical solutions. As road traffic accidents, severe injuries, and elective surgeries (orthopaedic, cardiovascular, neuro/spine) increase, demand for advanced hemostatic agents, sealants, and graft substitutes grows accordingly. This volume growth is especially pronounced in rapidly developing regions where infrastructure and hospital procedure counts are expanding.
Aging Population and Rising Prevalence Of Chronic Disorders
Another major driver is the global demographic shift toward an older population and corresponding increase in chronic diseases such as cardiovascular disorders, diabetes, and bone/joint degeneration. For example, the aging population is cited as significantly underpinning demand in biosurgery applications. As patients age, they are more likely to require surgical interventions (orthopaedic repairs, cardiovascular operations, wound/trauma care), which in turn increases demand for biosurgical consumables and implants (adhesives, hemostats, bone graft substitutes). Additionally, chronic wound care and complications from comorbidities further push the adoption of advanced biosurgical materials.
Advances In Biomaterials and Procedural Technologies Supporting Minimally Invasive Surgery
The third major driver is technological advancement in biosurgical products and the shift toward minimally invasive procedures. Innovations in sealants, adhesives, hemostatic agents, and graft materials have improved effectiveness, safety, and surgeon preference for biosurgical solutions over traditional sutures and staples. Furthermore, the rise of minimally invasive surgery (MIS) means less trauma, faster recovery, and a higher reliance on biosurgical adjuncts to achieve optimal outcomes, which drives demand. As more hospitals adopt MIS techniques and integrate biomaterial?enhanced products, biosurgery market growth is supported from the technology side as well as the procedural side.
Market Segmentation
- Based on the product type, the market is segmented into bone-graft substitutes, hemostatic agents, surgical sealants & adhesives, adhesion barriers, soft-tissue attachments, staple-line reinforcement, and others.
- Based on the application, the market is segmented into orthopedic surgery, general surgery, neurological surgery, cardiovascular surgery, gynecological surgery, and thoracic & reconstructive surgery.
- Based on the end user, the market is segmented into hospitals & clinics, ambulatory surgical centers (ASCs), and others.
Orthopedic Surgery Segment to Grow at a Considerable Market Share
Among all segments of the global biosurgery market, Orthopedic Surgery under the Application category is currently the largest and holds the dominant position. Orthopedic procedures often involve complex interventions such as bone reconstruction, spinal fusion, joint replacement, and trauma repair, all of which rely heavily on advanced biosurgical products, including bone-graft substitutes, hemostatic agents, and surgical sealants. The increasing prevalence of musculoskeletal disorders, such as osteoarthritis, osteoporosis, and bone fractures, particularly in aging populations, has significantly boosted demand for orthopedic biosurgical solutions. Furthermore, advancements in minimally invasive orthopedic procedures have elevated the need for precision surgical tools and bioactive materials that enhance healing and reduce complications. Hospitals and clinics, being the largest end-users for biosurgery, particularly for orthopedic procedures, further amplify the market dominance of this segment. In addition, rising sports-related injuries and the expansion of orthopedic care infrastructure in developing regions have contributed to sustained growth in this category. The combination of high procedural volumes, technological innovation, and a growing geriatric patient base ensures that orthopedic surgery continues to lead the global biosurgery market in both revenue and utilization.
Bone-Graft Substitutes: A Key Segment in Market Growth
In terms of market growth potential, bone-graft substitutes under the product type category are poised to be the fastest-growing segment in the global biosurgery market. Bone-graft substitutes, including synthetic grafts, demineralized bone matrix (DBM), and bioactive ceramics, are increasingly preferred over autografts and allografts due to reduced donor-site complications, improved safety, and enhanced osteoconductive and osteoinductive properties. Technological advancements, such as 3D-printed bone scaffolds and bioengineered grafts, have further fueled adoption in complex orthopedic, spinal, and craniofacial surgeries. The rising incidence of orthopedic and spinal disorders, coupled with an expanding pool of geriatric and trauma patients, has driven substantial demand for these substitutes. Additionally, growing awareness among surgeons regarding the benefits of synthetic and bioengineered grafts, such as faster healing times and lower risk of infection, has accelerated market uptake. Emerging markets in Asia-Pacific and Latin America, with increasing healthcare infrastructure and adoption of advanced surgical solutions, are also expected to contribute significantly to the growth trajectory of bone-graft substitutes. As a result, this product type is positioned as the key growth driver for the global biosurgery market over the forecast period.
Regional Outlook
The global biosurgery market is further divided by geography, including North America (the US and Canada), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), and the Rest of the World (the Middle East & Africa, and Latin America).
North America Region to Hold a Substantial Growth Rate
In North America, the US dominates the Global Biosurgery Market, holding the largest market share by a significant margin. This leadership is primarily driven by the country’s well-established healthcare infrastructure, high adoption of advanced surgical technologies, and a strong presence of leading biosurgery companies. The US healthcare system emphasizes minimally invasive surgeries and advanced patient care, which has fueled demand for innovative biosurgical products such as bone-graft substitutes, hemostatic agents, surgical sealants, and soft-tissue attachments. The rising prevalence of chronic diseases, including musculoskeletal disorders, cardiovascular conditions, and cancer, has further propelled the utilization of biosurgery solutions in hospitals, ambulatory surgical centers, and specialized clinics. Additionally, significant investment in research and development by both domestic and multinational companies has led to the rapid introduction of technologically advanced and clinically effective products, reinforcing the country’s dominance. Regulatory support, including guidance from the US Food and Drug Administration (FDA), ensures that high-quality and safe biosurgical products reach the market, boosting physician confidence and patient adoption. Moreover, the growing geriatric population in the United States, combined with increasing incidences of orthopedic injuries and surgeries, has created a robust demand pipeline for bone-graft substitutes and surgical sealants, which are critical in orthopedic, neurological, and cardiovascular surgeries. High healthcare expenditure per capita and widespread insurance coverage also facilitate the accessibility of these advanced surgical solutions to a large patient base. Collectively, these factors position the United States not only as the largest revenue contributor but also as a trendsetter in the global biosurgery market, influencing technological adoption, product development, and market dynamics worldwide. Emerging countries are growing rapidly, but the US remains the central hub for innovation, market penetration, and clinical application in the biosurgery industry.
Market Players Outlook
The major companies operating in the global biosurgery market include Baxter International Inc., Becton, Dickinson and Co., B.?Braun Melsungen?AG, Johnson &?Johnson Services, Inc., Medtronic plc, among others. Market players are leveraging partnerships, collaborations, mergers, and acquisitions to expand their businesses and develop innovative products to maintain their market positioning.
Recent Development
- In September 2024, HCAH partnered with Aroa Biosurgery to launch a Wound Care Initiative aimed at enhancing patient recovery. This initiative introduces new product lines from Aroa Biosurgery for the treatment of complex vascular and diabetic wounds. Additionally, HCAH has established the "WOW (Warriors of Woundcare) Nurses" program, which focuses on the prevention and treatment of bedsores in patients with limited mobility.
The Report Covers
- Market value data analysis for 2025 and forecast to 2035.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global biosurgery market. Based on the availability of data, information related to new products and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
- Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Global Biosurgery Market Sales Analysis – Product Type | Application | End-User ($ Million)
- Biosurgery Market Sales Performance of Top Countries
- Research Methodology
- Primary Research Approach
- Secondary Research Approach
- Market Snapshot
- Market Overview and Insights
- Scope of the Study
- Analyst Insight & Current Market Trends
- Key Biosurgery Market Trends
- Market Recommendations
- Market Determinants
- Market Drivers
- Drivers For Global Biosurgery Market: Impact Analysis
- Market Pain Points and Challenges
- Restraints For Global Biosurgery Market: Impact Analysis
- Market Opportunities
- Opportunities For Global Biosurgery Market: Impact Analysis
- Market Drivers
- Competitive Landscape
- Competitive Dashboard – Biosurgery Market Revenue and Share by Manufacturers
- Biosurgery Product Comparison Analysis
- Top Market Player Ranking Matrix
- Key Company Analysis
- Baxter International Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Becton, Dickinson and Co.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- ?Braun Melsungen?AG
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Johnson &?Johnson Services, Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Integra LifeSciences?Holdings Corp.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Top Winning Strategies by Market Players
- Merger and Acquisition
- Product Launch
- Partnership And Collaboration
- Baxter International Inc.
- Key Company Analysis
- Global Biosurgery Market Sales Analysis by Product Type ($ Million)
- Bone-Graft Substitutes
- Hemostatic Agents
- Surgical Sealants & Adhesives
- Adhesion Barriers
- Soft-Tissue Attachments
- Staple-Line Reinforcement
- Others
- Global Biosurgery Market Sales Analysis by Application ($ Million)
- Orthopedic Surgery
- General Surgery
- Neurological Surgery
- Cardiovascular Surgery
- Gynecological Surgery
- Thoracic & Reconstructive Surgery
- Global Biosurgery Market Sales Analysis by End User ($ Million)
- Hospitals & clinics
- Ambulatory Surgical Centers (ASCs)
- Others
- Regional Analysis
- North American Biosurgery Market Sales Analysis – Product Type | Application | End-User | Country ($ Million)
- Macroeconomic Factors for North America
- United States
- Canada
- European Biosurgery Market Sales Analysis – Product Type | Application | End-User | Country ($ Million)
- Macroeconomic Factors for Europe
- UK
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Asia-Pacific Biosurgery Market Sales Analysis – Product Type | Application | End-User | Country ($ Million)
- Macroeconomic Factors for Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia & New Zealand
- ASEAN Countries (Thailand, Indonesia, Vietnam, Singapore, And Other)
- Rest of Asia-Pacific
- Rest of the World Biosurgery Market Sales Analysis – Product Type | Application | End-User | Country ($ Million)
- Macroeconomic Factors for the Rest of the World
- Latin America
- Middle East and Africa
- Company Profiles
- Aroa Biosurgery Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Artivion, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- ?Braun Melsungen?AG
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Baxter International Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Becton, Dickinson and Company (BD)
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- CSL?Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Ethicon (a J&J company)
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Hemostasis?LLC
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Integra LifeSciences?Holdings Corp.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Johnson &?Johnson Services, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Kuros Biosciences AG
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Medtronic plc
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Meril?Lifesciences Pvt.?Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Nanosonics?Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Orthofix Medical Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Samyang Holdings Corp.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Smith &?Nephew?plc
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Stryker Corp.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Teleflex Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Terumo Corp.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Tissue?Regenix?Group?plc
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- ?L.?Gore?&?Associates
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Zimmer?Biomet Holdings, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Aroa Biosurgery Ltd.
1. Global Biosurgery Market Research and Analysis by Product Type, 2025–2035 ($ Million)
2. Global Bone-Graft Substitutes Biosurgery Market Research and Analysis by Region, 2025–2035 ($ Million)
3. Global Hemostatic Agents Biosurgery Market Research and Analysis by Region, 2025–2035 ($ Million)
4. Global Surgical Sealants & Adhesives Biosurgery Market Research and Analysis by Region, 2025–2035 ($ Million)
5. Global Adhesion Barriers Biosurgery Market Research and Analysis by Region, 2025–2035 ($ Million)
6. Global Soft-Tissue Attachments Biosurgery Market Research and Analysis by Region, 2025–2035 ($ Million)
7. Global Staple-Line Reinforcement Biosurgery Market Research and Analysis by Region, 2025–2035 ($ Million)
8. Global Other Product Type Biosurgery Market Research and Analysis by Region, 2025–2035 ($ Million)
9. Global Biosurgery Market Research and Analysis by Application, 2025–2035 ($ Million)
10. Global Biosurgery In Orthopedic Surgery Market Research And Analysis By Region, 2025–2035 ($ Million)
11. Global Biosurgery In General Surgery Market Research And Analysis By Region, 2025–2035 ($ Million)
12. Global Biosurgery In Neurological Surgery Market Research And Analysis By Region, 2025–2035 ($ Million)
13. Global Biosurgery In Cardiovascular Surgery Market Research And Analysis By Region, 2025–2035 ($ Million)
14. Global Biosurgery In Gynecological Surgery Market Research And Analysis By Region, 2025–2035 ($ Million)
15. Global Biosurgery In Hardware Thoracic & Reconstructive Surgery Market Research And Analysis By Region, 2025–2035 ($ Million)
16. Global Biosurgery Market Research and Analysis by End User, 2025–2035 ($ Million)
17. Global Biosurgery For Hospitals & clinics Market Research And Analysis By Region, 2025–2035 ($ Million)
18. Global Biosurgery For Ambulatory Surgical Centers (ASCs) Market Research And Analysis By Region, 2025–2035 ($ Million)
19. Global Biosurgery For Other End User Market Research And Analysis By Region, 2025–2035 ($ Million)
20. Global Biosurgery Market Research and Analysis by Region, 2025–2035 ($ Million)
21. North American Biosurgery Market Research and Analysis by Country, 2025–2035 ($ Million)
22. North American Biosurgery Market Research and Analysis by Product Type, 2025–2035 ($ Million)
23. North American Biosurgery Market Research and Analysis by Application, 2025–2035 ($ Million)
24. North American Biosurgery Market Research and Analysis by End User, 2025–2035 ($ Million)
25. European Biosurgery Market Research and Analysis by Country, 2025–2035 ($ Million)
26. European Biosurgery Market Research and Analysis by Product Type, 2025–2035 ($ Million)
27. European Biosurgery Market Research and Analysis by Application, 2025–2035 ($ Million)
28. European Biosurgery Market Research and Analysis by End User, 2025–2035 ($ Million)
29. Asia-Pacific Biosurgery Market Research and Analysis by Country, 2025–2035 ($ Million)
30. Asia-Pacific Biosurgery Market Research and Analysis by Product Type, 2025–2035 ($ Million)
31. Asia-Pacific Biosurgery Market Research and Analysis by Application, 2025–2035 ($ Million)
32. Asia-Pacific Biosurgery Market Research and Analysis by End User, 2025–2035 ($ Million)
33. Rest of the World Biosurgery Market Research and Analysis by Region, 2025–2035 ($ Million)
34. Rest of the World Biosurgery Market Research and Analysis by Product Type, 2025–2035 ($ Million)
35. Rest of the World Biosurgery Market Research and Analysis by Application, 2025–2035 ($ Million)
36. Rest of the World Biosurgery Market Research and Analysis by End User, 2025–2035 ($ Million)
1. Global Biosurgery Market Share by Product Type, 2025 Vs 2035 (%)
2. Global Bone-Graft Substitutes Biosurgery Market Share by Region, 2025 Vs 2035 (%)
3. Global Hemostatic Agents Biosurgery Market Share by Region, 2025 Vs 2035 (%)
4. Global Surgical Sealants & Adhesives Biosurgery Market Share by Region, 2025 Vs 2035 (%)
5. Global Adhesion Barriers Biosurgery Market Share by Region, 2025 Vs 2035 (%)
6. Global Soft-Tissue Attachments Biosurgery Market Share by Region, 2025 Vs 2035 (%)
7. Global Staple-Line Reinforcement Biosurgery Market Share by Region, 2025 Vs 2035 (%)
8. Global Other Product Type Biosurgery Market Share by Region, 2025 Vs 2035 (%)
9. Global Biosurgery Market Share by Application, 2025 Vs 2035 (%)
10. Global Biosurgery in Orthopedic Surgery Market Share by Region, 2025 Vs 2035 (%)
11. Global Biosurgery in General Surgery Market Share by Region, 2025 Vs 2035 (%)
12. Global Biosurgery in Neurological Surgery Market Share by Region, 2025 Vs 2035 (%)
13. Global Biosurgery in Cardiovascular Surgery Market Share by Region, 2025 Vs 2035 (%)
14. Global Biosurgery in Gynecological Surgery Market Share by Region, 2025 Vs 2035 (%)
15. Global Biosurgery in Hardware, Thoracic & Reconstructive Surgery Market Share by Region, 2025 Vs 2035 (%)
16. Global Biosurgery Market Share by End User, 2025 Vs 2035 (%)
17. Global Biosurgery for Hospitals & Clinics Market Share by Region, 2025 Vs 2035 (%)
18. Global Biosurgery for Ambulatory Surgical Centers (ASCs) Market Share by Region, 2025 Vs 2035 (%)
19. Global Biosurgery for Other End Users Market Share by Region, 2025 Vs 2035 (%)
20. Global Biosurgery Market Share by Region, 2025 Vs 2035 (%)
21. US Biosurgery Market Size, 2025–2035 ($ Million)
22. Canada Biosurgery Market Size, 2025–2035 ($ Million)
23. UK Biosurgery Market Size, 2025–2035 ($ Million)
24. France Biosurgery Market Size, 2025–2035 ($ Million)
25. Germany Biosurgery Market Size, 2025–2035 ($ Million)
26. Italy Biosurgery Market Size, 2025–2035 ($ Million)
27. Spain Biosurgery Market Size, 2025–2035 ($ Million)
28. Russia Biosurgery Market Size, 2025–2035 ($ Million)
29. Rest of Europe Biosurgery Market Size, 2025–2035 ($ Million)
30. India Biosurgery Market Size, 2025–2035 ($ Million)
31. China Biosurgery Market Size, 2025–2035 ($ Million)
32. Japan Biosurgery Market Size, 2025–2035 ($ Million)
33. South Korea Biosurgery Market Size, 2025–2035 ($ Million)
34. Australia and New Zealand Biosurgery Market Size, 2025–2035 ($ Million)
35. ASEAN Economies Biosurgery Market Size, 2025–2035 ($ Million)
36. Rest of Asia-Pacific Biosurgery Market Size, 2025–2035 ($ Million)
37. Latin America Biosurgery Market Size, 2025–2035 ($ Million)
38. Middle East and Africa Biosurgery Market Size, 2025–2035 ($ Million)
- Printable version
- No restriction to number of user within the company
Contact Sales
FAQS
The size of the Biosurgery Market in 2025 is estimated to be around $16.9 billion.
North America holds the largest share in the Biosurgery Market.
Leading players in the Biosurgery Market include Baxter International Inc., Becton, Dickinson and Co., B. Braun Melsungen AG, Johnson & Johnson Services, Inc., Medtronic plc, among others.
Biosurgery Market is expected to grow at a CAGR of 7.7% from 2026 to 2035.
Rising prevalence of chronic diseases, advancements in minimally invasive surgical technologies, and increasing demand for precision surgical procedures are driving the Biosurgery Market growth.
